Watch Ticker

Enliven Therapeutics, Inc. Common Stock

Go to Enliven Therapeutics, Inc. Common Stock Website

$19.08

0.34 (1.81%)

Live

Previous Close

$18.74

Day Range

$18.52 - $19.27

Previous Day Range

$18.415 - $19.33

Market Cap

$1.1 billion USD

Day Vol.

353011

Previous Day Vol.

273183

Currency

USD

Primary Exchange

Nasdaq

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks - Enliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why

Enliven Therapeutics (ELVN) is a good choice for trend investors due to its recent price increase, positive earnings estimate revisions, and strong fundamentals, making it a Zacks Rank #2 (Buy) stock.

Related tickers: ELVN.

Read Full Article

N/A - Enliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia

Enliven Therapeutics reported positive data from a Phase 1 trial of its drug ELVN-001for chronic myeloid leukemia, with a 44% major molecular response rate by 24 weeks and a favorable safety profile.

Related tickers: ELVN.

Read Full Article

Trending Tickers

Please sign in to view